Shows
ASTRO JournalsASTRO clinical practice guideline of Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell CarcinomaIn this PRO podcast, Bisham Chera MD, FASTRO, Danielle Margalit, MD, MPH, and David Sher, MD, discuss the recently published ASTRO clinical practice guideline of Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma. This manuscript was published in print in the September/October 2024 issue and was the 3rd most downloaded PRO article in 2024. Listen for their lively and meaningful discussion of the key recommendations and controversies.2025-02-2847 min
ASTRO JournalsASTRO clinical practice guideline of Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell CarcinomaSend us a textIn this PRO podcast, Bisham Chera MD, FASTRO, Danielle Margalit, MD, MPH, and David Sher, MD, discuss the recently published ASTRO clinical practice guideline of Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma. This manuscript was published in print in the September/October 2024 issue and was the 3rd most downloaded PRO article in 2024. Listen for their lively and meaningful discussion of the key recommendations and controversies.2025-02-2847 minASTRO JournalsThe Red Journal Oncology Scan PodcastThere are few fully accrued contemporary studies that randomize patients to surgery or radiation for curative treatment of a solid tumor. Featured in the April 1 Oncology Scan, the ORATOR 1 clinical trial is one such study of head and neck cancer that compared primary transoral robotic surgery (TORS) versus radiation therapy (RT) for treatment of oropharynx cancer, with a patient reported quality of life primary endpoint. Join Red Journal Associate Editor Danielle Margalit, MD as she discusses the trial with authors Anthony Nichols, MD, FRCSC, FACS and David Palma, MD, PhD, FRCPC, and with special guest, Kate Hutcheson, PhD, speech pathologist...2020-03-1234 minASTRO JournalsThe Red Journal Oncology Scan PodcastSend us a textThere are few fully accrued contemporary studies that randomize patients to surgery or radiation for curative treatment of a solid tumor. Featured in the April 1 Oncology Scan, the ORATOR 1 clinical trial is one such study of head and neck cancer that compared primary transoral robotic surgery (TORS) versus radiation therapy (RT) for treatment of oropharynx cancer, with a patient reported quality of life primary endpoint. Join Red Journal Associate Editor Danielle Margalit, MD as she discusses the trial with authors Anthony Nichols, MD, FRCSC, FACS and David Palma, MD, PhD, FRCPC, and with special...2020-03-1234 min